NASDAQ:BSGM BioSig Technologies (BSGM) Stock Price, News & Analysis → The Worst is Yet to Come… (From Porter & Company) (Ad) Free BSGM Stock Alerts $2.29 +0.23 (+11.04%) (As of 11:09 AM ET) Add Compare Share Share Today's Range$2.05▼$2.3850-Day Range$0.47▼$2.0652-Week Range$0.26▼$16.40Volume324,016 shsAverage Volume768,211 shsMarket Capitalization$28.55 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get BioSig Technologies alerts: Email Address Ad Porter & CompanyHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. About BioSig Technologies Stock (NASDAQ:BSGM)BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.Read More BSGM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BSGM Stock News HeadlinesMay 21, 2024 | globenewswire.comBioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to ShareholdersMay 3, 2024 | globenewswire.comBioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 IndependentApril 30, 2024 | marketwatch.comBioSig Technologies Appoints Amato as CEO Following Engagement With Consulting FirmApril 30, 2024 | globenewswire.comBioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective ImmediatelyApril 18, 2024 | thestreet.comBioSig Technologies Inc.April 10, 2024 | msn.comAptevo Therapeutics, TRACON Pharmaceuticals, Biosig Technologies among healthcare moversApril 8, 2024 | msn.comU.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.03%April 4, 2024 | finance.yahoo.comBioSig Engages Consulting Firm for Business Model StrategiesApril 4, 2024 | globenewswire.comBioSig Engages Consulting Firm for Business Model StrategiesFebruary 29, 2024 | investing.comBiosig Technologies Inc (BSGM)February 23, 2024 | msn.comU.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.13%February 22, 2024 | benzinga.comBioSig Technologies Stock (NASDAQ:BSGM) Earnings Dates and Earning CallsFebruary 21, 2024 | msn.comU.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.13%February 20, 2024 | finance.yahoo.comBioSig Announces Reduction of its WorkforceFebruary 20, 2024 | globenewswire.comBioSig Announces Reduction of its WorkforceFebruary 7, 2024 | msn.comBioSig Technologies Marks 100 Cases with Tracking AlgorithmFebruary 6, 2024 | stockhouse.comBioSig's PURE EP(TM) Platform with New Near Field Tracking Algorithm Surpasses 100 Patient CasesFebruary 6, 2024 | finance.yahoo.comBioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient CasesFebruary 2, 2024 | msn.comBioSig Technologies Slashes Workforce, Halves Cash BurnFebruary 2, 2024 | msn.comBioSig Technologies Announces Executive Team RestructuringJanuary 30, 2024 | finance.yahoo.comBioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core StrategyDecember 30, 2023 | benzinga.comBioSig Technologies Stock (NASDAQ:BSGM) Dividends: History, Yield and DatesDecember 12, 2023 | finance.yahoo.comShareholders May Not Be So Generous With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation And Here's WhyDecember 8, 2023 | morningstar.comBioSig Technologies Inc BSGMNovember 27, 2023 | msn.comBiosig Technologies (BSGM) Price Target Increased by 38.89% to 5.74See More Headlines Receive BSGM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioSig Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/31/2022Today5/29/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:BSGM CUSIPN/A CIK1530766 Webwww.biosig.com Phone(230) 409-5444FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-29,040,000.00 Net MarginsN/A Pretax Margin-91,566.66% Return on Equity-8,129.09% Return on Assets-951.37% Debt Debt-to-Equity RatioN/A Current Ratio0.14 Quick Ratio0.14 Sales & Book Value Annual Sales$20,000.00 Price / Sales1,285.44 Cash FlowN/A Price / Cash FlowN/A Book Value($0.33) per share Price / Book-6.24Miscellaneous Outstanding Shares12,480,000Free Float11,316,000Market Cap$25.71 million OptionableOptionable Beta0.70 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Frederick D. Hrkac (Age 58)President, Principal Executive Officer, Executive VP & Director Mr. Anthony Amato (Age 56)CEO & Director Dr. Budimir S. Drakulic Ph.D. (Age 74)Chief Scientist Comp: $169.64kMr. Andrew Gornell BallouVice President of Investor RelationsKey CompetitorsRockwell MedicalNASDAQ:RMTIFONARNASDAQ:FONRVivani MedicalNASDAQ:VANIHyperfineNASDAQ:HYPRelectroCoreNASDAQ:ECORView All CompetitorsInsiders & InstitutionsPFG Investments LLCSold 51,454 shares on 4/22/2024Ownership: 0.948%Kenneth L LondonerBought 600 shares on 6/12/2023Total: $7,020.00 ($11.70/share)View All Insider TransactionsView All Institutional Transactions BSGM Stock Analysis - Frequently Asked Questions How have BSGM shares performed in 2024? BioSig Technologies' stock was trading at $4.75 at the start of the year. Since then, BSGM shares have decreased by 56.4% and is now trading at $2.07. View the best growth stocks for 2024 here. Are investors shorting BioSig Technologies? BioSig Technologies saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 461,700 shares, a decline of 10.2% from the April 30th total of 514,300 shares. Based on an average trading volume of 1,120,000 shares, the days-to-cover ratio is presently 0.4 days. Currently, 4.6% of the company's shares are short sold. View BioSig Technologies' Short Interest. When is BioSig Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024. View our BSGM earnings forecast. How were BioSig Technologies' earnings last quarter? BioSig Technologies, Inc. (NASDAQ:BSGM) issued its earnings results on Thursday, March, 31st. The company reported ($2.40) earnings per share for the quarter, missing the consensus estimate of ($2.20) by $0.20. When did BioSig Technologies' stock split? BioSig Technologies shares reverse split before market open on Friday, February 2nd 2024. The 1-10 reverse split was announced on Friday, February 2nd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 2nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of BioSig Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Roku (ROKU), Advanced Micro Devices (AMD), Amarin (AMRN), Dynavax Technologies (DVAX), Vaxart (VXRT), Telefonaktiebolaget LM Ericsson (publ) (ERIC) and Micron Technology (MU). Who are BioSig Technologies' major shareholders? BioSig Technologies' stock is owned by a number of retail and institutional investors. Top institutional shareholders include PFG Investments LLC (0.95%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Gray Fleming, John Sieckhaus, Kenneth L Londoner, Kenneth L Londoner, Patrick Joseph Gallagher and Steve Chaussy. View institutional ownership trends. How do I buy shares of BioSig Technologies? Shares of BSGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BSGM) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarNext President (Not Trump. Not Biden.)The Freeport SocietyWrite this ticker symbol down…StocksToTradeNvidia’s Quiet $1 Trillion PivotWeiss Ratings4 Cryptos BETTER than BitcoinTrue Market Insiders[Urgent!] Generational Wealth GameplanCrypto 101 MediaDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThe only AI company to buyPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
